US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.280
  • +0.342+36.46%
Close Dec 20 16:00 ET
  • 1.240
  • -0.040-3.13%
Post 19:59 ET
56.27MMarket Cap-0.83P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.27%-13.67M
220.39%19.95M
58.41%-10.5M
9.38%-68.62M
26.32%-13.43M
32.85%-13.37M
1.09%-16.57M
-21.19%-25.25M
6.23%-75.72M
-6.18%-18.22M
Net income from continuing operations
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
15.37%-16.75M
21.36%-19.36M
-6.06%-22.65M
-16.39%-88.22M
-14.03%-22.47M
Operating gains losses
----
----
----
200.00%3K
--0
--1K
----
----
-99.55%1K
--0
Depreciation and amortization
-17.17%381K
-9.55%445K
-11.22%443K
2.87%1.9M
-8.18%449K
-2.75%460K
10.56%492K
13.41%499K
23.22%1.85M
24.11%489K
Other non cash items
--0
--0
-103.23%-1K
-29.60%157K
-72.88%16K
-60.34%23K
64.15%87K
-41.51%31K
28.90%223K
13.46%59K
Change In working capital
-255.61%-1.61M
7,880.50%31.92M
189.87%4.43M
-182.73%-1.66M
-2.50%1.83M
141.00%1.03M
-91.40%400K
-145.76%-4.93M
116.98%2M
10,344.44%1.88M
-Change in receivables
----
----
---30M
----
----
----
----
--0
----
----
-Change in prepaid assets
160.56%1.01M
223.68%2.15M
-538.92%-1.78M
100.00%688K
236.85%1.29M
-491.08%-1.67M
27.26%663K
20.83%406K
110.97%344K
-303.69%-939K
-Change in payables and accrued expense
-107.98%-225K
1,661.38%2.26M
46.44%-2.8M
-191.21%-1.89M
-77.27%665K
199.12%2.82M
-103.42%-145K
-132.58%-5.23M
124.54%2.07M
936.00%2.93M
-Change in other current assets
17.09%137K
16.81%132K
17.59%127K
17.65%460K
18.45%122K
17.00%117K
17.71%113K
17.39%108K
17.77%391K
17.05%103K
-Change in other current liabilities
-13.62%-267K
-13.85%-263K
-14.55%-244K
-14.61%-918K
-13.81%-239K
-14.63%-235K
-14.93%-231K
-15.14%-213K
-42.02%-801K
-16.02%-210K
-Change in other working capital
---2.26M
---2.36M
--39.12M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-2.27%-13.67M
220.39%19.95M
58.41%-10.5M
9.38%-68.62M
26.32%-13.43M
32.85%-13.37M
1.09%-16.57M
-21.19%-25.25M
6.23%-75.72M
-6.18%-18.22M
Investing cash flow
Cash flow from continuing investing activities
-9K
93.35%-21K
0
73.97%-486K
0
0
59.01%-316K
33.07%-170K
-69.73%-1.87M
-34.66%-509K
Net PPE purchase and sale
---9K
93.35%-21K
--0
73.97%-486K
--0
--0
59.01%-316K
33.07%-170K
-69.73%-1.87M
-34.66%-509K
Cash from discontinued investing activities
Investing cash flow
---9K
93.35%-21K
--0
73.97%-486K
--0
--0
59.01%-316K
33.07%-170K
-69.73%-1.87M
-34.66%-509K
Financing cash flow
Cash flow from continuing financing activities
99.87%-3K
2,120.46%20.04M
156.52%954K
-9,392.75%-6.55M
-7,680.95%-1.63M
-10,063.64%-2.24M
-4,623.81%-992K
-33,660.00%-1.69M
-100.03%-69K
-100.02%-21K
Net issuance payments of debt
99.69%-7K
98.14%-21K
-98.70%-3.35M
-7,843.53%-6.75M
-7,938.10%-1.69M
-10,100.00%-2.24M
-5,290.48%-1.13M
-7,938.10%-1.69M
22.73%-85K
4.55%-21K
Net common stock issuance
--0
--2.52M
--4.31M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
-50.00%4K
----
----
1,162.50%202K
--54K
--8K
----
----
-94.35%16K
--0
Cash from discontinued financing activities
Financing cash flow
99.87%-3K
2,120.46%20.04M
156.52%954K
-9,392.75%-6.55M
-7,680.95%-1.63M
-10,063.64%-2.24M
-4,623.81%-992K
-33,660.00%-1.69M
-100.03%-69K
-100.02%-21K
Net cash flow
Beginning cash position
-0.31%76.72M
-61.26%36.74M
-62.04%46.29M
-38.91%121.95M
-56.40%61.35M
-52.19%76.96M
-46.87%94.84M
-38.91%121.95M
860.15%199.61M
38.87%140.7M
Current changes in cash
12.31%-13.68M
323.55%39.98M
64.78%-9.55M
2.58%-75.66M
19.69%-15.06M
22.99%-15.61M
-1.90%-17.88M
-28.51%-27.11M
-143.43%-77.66M
-119.08%-18.75M
End cash Position
2.74%63.03M
-0.31%76.72M
-61.26%36.74M
-62.04%46.29M
-62.04%46.29M
-56.40%61.35M
-52.19%76.96M
-46.87%94.84M
-38.91%121.95M
-38.91%121.95M
Free cash flow
-2.33%-13.68M
218.01%19.93M
58.69%-10.5M
10.93%-69.11M
28.32%-13.43M
33.95%-13.37M
3.63%-16.89M
-20.54%-25.42M
5.21%-77.59M
-6.80%-18.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.27%-13.67M220.39%19.95M58.41%-10.5M9.38%-68.62M26.32%-13.43M32.85%-13.37M1.09%-16.57M-21.19%-25.25M6.23%-75.72M-6.18%-18.22M
Net income from continuing operations 16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M15.37%-16.75M21.36%-19.36M-6.06%-22.65M-16.39%-88.22M-14.03%-22.47M
Operating gains losses ------------200.00%3K--0--1K---------99.55%1K--0
Depreciation and amortization -17.17%381K-9.55%445K-11.22%443K2.87%1.9M-8.18%449K-2.75%460K10.56%492K13.41%499K23.22%1.85M24.11%489K
Other non cash items --0--0-103.23%-1K-29.60%157K-72.88%16K-60.34%23K64.15%87K-41.51%31K28.90%223K13.46%59K
Change In working capital -255.61%-1.61M7,880.50%31.92M189.87%4.43M-182.73%-1.66M-2.50%1.83M141.00%1.03M-91.40%400K-145.76%-4.93M116.98%2M10,344.44%1.88M
-Change in receivables -----------30M------------------0--------
-Change in prepaid assets 160.56%1.01M223.68%2.15M-538.92%-1.78M100.00%688K236.85%1.29M-491.08%-1.67M27.26%663K20.83%406K110.97%344K-303.69%-939K
-Change in payables and accrued expense -107.98%-225K1,661.38%2.26M46.44%-2.8M-191.21%-1.89M-77.27%665K199.12%2.82M-103.42%-145K-132.58%-5.23M124.54%2.07M936.00%2.93M
-Change in other current assets 17.09%137K16.81%132K17.59%127K17.65%460K18.45%122K17.00%117K17.71%113K17.39%108K17.77%391K17.05%103K
-Change in other current liabilities -13.62%-267K-13.85%-263K-14.55%-244K-14.61%-918K-13.81%-239K-14.63%-235K-14.93%-231K-15.14%-213K-42.02%-801K-16.02%-210K
-Change in other working capital ---2.26M---2.36M--39.12M----------------------------
Cash from discontinued investing activities
Operating cash flow -2.27%-13.67M220.39%19.95M58.41%-10.5M9.38%-68.62M26.32%-13.43M32.85%-13.37M1.09%-16.57M-21.19%-25.25M6.23%-75.72M-6.18%-18.22M
Investing cash flow
Cash flow from continuing investing activities -9K93.35%-21K073.97%-486K0059.01%-316K33.07%-170K-69.73%-1.87M-34.66%-509K
Net PPE purchase and sale ---9K93.35%-21K--073.97%-486K--0--059.01%-316K33.07%-170K-69.73%-1.87M-34.66%-509K
Cash from discontinued investing activities
Investing cash flow ---9K93.35%-21K--073.97%-486K--0--059.01%-316K33.07%-170K-69.73%-1.87M-34.66%-509K
Financing cash flow
Cash flow from continuing financing activities 99.87%-3K2,120.46%20.04M156.52%954K-9,392.75%-6.55M-7,680.95%-1.63M-10,063.64%-2.24M-4,623.81%-992K-33,660.00%-1.69M-100.03%-69K-100.02%-21K
Net issuance payments of debt 99.69%-7K98.14%-21K-98.70%-3.35M-7,843.53%-6.75M-7,938.10%-1.69M-10,100.00%-2.24M-5,290.48%-1.13M-7,938.10%-1.69M22.73%-85K4.55%-21K
Net common stock issuance --0--2.52M--4.31M----------0--0--0--------
Proceeds from stock option exercised by employees -50.00%4K--------1,162.50%202K--54K--8K---------94.35%16K--0
Cash from discontinued financing activities
Financing cash flow 99.87%-3K2,120.46%20.04M156.52%954K-9,392.75%-6.55M-7,680.95%-1.63M-10,063.64%-2.24M-4,623.81%-992K-33,660.00%-1.69M-100.03%-69K-100.02%-21K
Net cash flow
Beginning cash position -0.31%76.72M-61.26%36.74M-62.04%46.29M-38.91%121.95M-56.40%61.35M-52.19%76.96M-46.87%94.84M-38.91%121.95M860.15%199.61M38.87%140.7M
Current changes in cash 12.31%-13.68M323.55%39.98M64.78%-9.55M2.58%-75.66M19.69%-15.06M22.99%-15.61M-1.90%-17.88M-28.51%-27.11M-143.43%-77.66M-119.08%-18.75M
End cash Position 2.74%63.03M-0.31%76.72M-61.26%36.74M-62.04%46.29M-62.04%46.29M-56.40%61.35M-52.19%76.96M-46.87%94.84M-38.91%121.95M-38.91%121.95M
Free cash flow -2.33%-13.68M218.01%19.93M58.69%-10.5M10.93%-69.11M28.32%-13.43M33.95%-13.37M3.63%-16.89M-20.54%-25.42M5.21%-77.59M-6.80%-18.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%